A detailed history of Met Life Investment Management, LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 43,601 shares of WVE stock, worth $589,049. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43,601
Previous 43,601 -0.0%
Holding current value
$589,049
Previous $217,000 64.52%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$4.38 - $6.48 $24,234 - $35,853
5,533 Added 14.53%
43,601 $217,000
Q1 2024

May 14, 2024

BUY
$3.54 - $6.84 $134,760 - $260,385
38,068 New
38,068 $234,000
Q2 2023

Apr 29, 2024

BUY
$3.51 - $4.69 $110,294 - $147,373
31,423 New
31,423 $114,000
Q2 2023

Aug 10, 2023

BUY
$3.51 - $4.69 $110,294 - $147,373
31,423 New
31,423 $114,000
Q4 2020

May 24, 2024

BUY
$6.99 - $9.26 $32,517 - $43,077
4,652 Added 41.44%
15,877 $124,000
Q4 2020

Jun 22, 2023

BUY
$6.99 - $9.26 $110,980 - $147,021
15,877 New
15,877 $125 Million
Q3 2020

May 24, 2024

BUY
$8.49 - $19.54 $3,115 - $7,171
367 Added 3.38%
11,225 $95.3 Million
Q3 2020

Jun 26, 2023

BUY
$8.49 - $19.54 $95,300 - $219,336
11,225 New
11,225 $95.3 Million
Q2 2020

May 24, 2024

SELL
$7.44 - $11.29 $202,442 - $307,200
-27,210 Reduced 71.48%
10,858 $113 Million
Q2 2020

Jun 26, 2023

BUY
$7.44 - $11.29 $80,783 - $122,586
10,858 New
10,858 $113 Million
Q1 2020

Jul 12, 2023

BUY
$6.94 - $14.22 $75,354 - $154,400
10,858 New
10,858 $102 Million
Q4 2019

Jul 12, 2023

BUY
$7.99 - $37.6 $86,755 - $408,260
10,858 New
10,858 $87 Million
Q3 2019

Jul 12, 2023

BUY
$19.17 - $27.4 $208,147 - $297,509
10,858 New
10,858 $223 Million
Q2 2019

Jul 12, 2023

BUY
$22.93 - $42.84 $196,533 - $367,181
8,571 New
8,571 $224 Million
Q1 2019

Jul 13, 2023

BUY
$32.69 - $47.91 $280,185 - $410,636
8,571 New
8,571 $333 Million

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.17B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.